ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

TERN Terns Pharmaceuticals Inc

5.44
0.15 (2.84%)
After Hours
Last Updated: 16:09:52
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Terns Pharmaceuticals Inc TERN NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.15 2.84% 5.44 16:09:52
Open Price Low Price High Price Close Price Previous Close
5.39 5.21 5.57 5.44 5.29
more quote information »

Recent News

Date Time Source Heading
5/03/202415:05GLOBETerns Pharmaceuticals Reports Inducement Grant to New..
4/29/202415:05GLOBETerns Pharmaceuticals Announces Data from Ongoing Phase 1..
4/10/202415:05GLOBETerns Pharmaceuticals Appoints Melita Sun Jung as Chief..
3/14/202415:05GLOBETerns Pharmaceuticals Reports Fourth Quarter and Full Year..
3/11/202415:05GLOBETerns Pharmaceuticals Announces Orphan Drug Designation..
3/07/202415:05GLOBETerns Pharmaceuticals Reports Inducement Grant to New..
3/05/202417:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/27/202415:05GLOBETerns Pharmaceuticals to Participate in Upcoming March..
2/15/202417:02EDGAR2Form 3 - Initial statement of beneficial ownership of..
2/14/202407:57EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/07/202415:20EDGAR2Form 8-K - Current report
2/07/202415:05GLOBETerns Pharmaceuticals Reports Inducement Grants to New Chief..
2/07/202407:05GLOBETerns Pharmaceuticals Appoints Amy Burroughs as Chief..
2/02/202415:05GLOBETerns Pharmaceuticals Reports Inducement Grant to New..
1/25/202418:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/04/202415:05GLOBETerns Pharmaceuticals to Highlight 2024 Priorities and..
1/03/202415:05GLOBETerns Pharmaceuticals Reports Inducement Grant to New..
11/29/202315:05GLOBETerns Pharmaceuticals to Present at the JMP Securities..
11/27/202315:05GLOBETerns Pharmaceuticals Mourns the Loss of Senthil Sundaram,..
11/14/202307:05GLOBETerns Pharmaceuticals Reports Third Quarter 2023 Financial..
11/13/202307:05GLOBETerns Pharmaceuticals Presents Late-Breaking Data from Phase..
11/09/202307:05GLOBETerns Pharmaceuticals to Participate in Upcoming November..
11/03/202315:05GLOBETerns Pharmaceuticals Reports Inducement Grants to New..
11/02/202315:05GLOBETerns Pharmaceuticals Announces First Participant Dosed in..
10/19/202315:05GLOBETerns Pharmaceuticals to Participate in Upcoming Investor..
10/16/202307:05GLOBETerns Pharmaceuticals Announces Global Phase 1 Clinical..
10/10/202315:33EDGAR2Form 8-K - Current report
10/03/202315:05GLOBETerns Pharmaceuticals Reports Inducement Grants to New..
9/06/202315:05GLOBETerns Pharmaceuticals Reports Inducement Grants to New..
9/05/202315:05GLOBETerns Pharmaceuticals to Participate in Upcoming September..
8/08/202315:53EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/08/202315:24EDGAR2Form 8-K - Current report
8/08/202315:15GLOBETerns Pharmaceuticals Reports Second Quarter 2023 Financial..
8/08/202315:05GLOBETerns Achieves Primary Endpoint and All Secondary Endpoints..
8/03/202317:00GLOBETerns Pharmaceuticals Reports Inducement Grant to New..
8/03/202316:22EDGAR2Form 8-K - Current report
8/03/202316:05GLOBETerns Pharmaceuticals Announces Leadership Transition
7/18/202315:05GLOBETerns Pharmaceuticals to Host Virtual Key Opinion Leader..
7/05/202315:05GLOBETerns Pharmaceuticals Reports Inducement Grants to New..
6/26/202315:05GLOBETerns Pharmaceuticals Highlights New Preclinical Data for..
6/06/202315:30GLOBETerns Pharmaceuticals to Present at Goldman Sachs 44th..
6/02/202315:05GLOBETerns Pharmaceuticals Reports Inducement Grants to New..
5/25/202316:05GLOBETerns Pharmaceuticals Announces Publication of TERN-701..
5/24/202315:05GLOBETerns Pharmaceuticals to Present at Upcoming Investor..
5/22/202315:05GLOBETerns Pharmaceuticals to Highlight New Preclinical Data for..
5/15/202307:05GLOBETerns Pharmaceuticals Reports First Quarter 2023 Financial..
5/09/202315:05GLOBETerns Pharmaceuticals to Participate in the JMP Securities..

Your Recent History

Delayed Upgrade Clock